Are anti-vaxxers’ religious exemption claims grounded in actual religious laws?
Alina Dain Sharon
As the debate on vaccination heats up again in the U.S., some “anti-vaxxers” are requesting exemptions from vaccinating their chil-dren on religious grounds. But what do their faiths, including Judaism, actually say about the issue?
JScreen allows Jews to test for hereditary diseases with mail-in saliva test.
An innovative, Atlanta-based screening program for Jewish genetic diseases has expanded its geographic scope and medical capabilities since it was founded a year and a half ago — and, with the help of one supporter from Long Island, recently reached nearly 200 Jewish college students on one campus in one day.
Jerusalem — A pair of young Israeli entrepreneurs have developed an ADHD treatment app that they say will soon provide an affordable and readily accessible alternative to ADHD medications and prohibitively expensive brain-training (cognitive) treatments already being offered at specialized clinics.
Ben-Gurion University team seen making headway with testing, outreach.
There has been a 30 percent reduction in the infant mortality rate in Israel’s Bedouin community of southern Israel during the past few years, and much of that success is due to the diagnosis and prevention of many genetic diseases that have plagued the community for centuries Much of the research into these diseases, which can cause everything from severe developmental delays and fatal heart malformations to blindness and immune deficiencies, has been taking place in the southern city of Beersheva under the leadership of Dr. Ohad Birk.
Battling genetic disease among the Bedouins. Silicon Valley BRCA testing kit making waves in market. Atlanta-based screening program expanding reach. Israeli app for ADHD gaining traction. The silence of infertility.
Einstein-affiliated Jewish genetic health program joins with Montefiore on BRCA1/2 screening.
Beginning this week, the Program for Jewish Genetic Health, a nonprofit affiliated with Yeshiva University and the school’s Albert Einstein College of Medicine, is teaming up with Montefiore Health System to offer subsidized genetic testing for Ashkenazi women and men who might be carriers of the BRCA1/2 genes for breast cancer. The cost for the test is $100. To discuss the test and broader questions about breast cancer, The Jewish Week spoke with Dr. Susan Klugman, medical director for the Program for Jewish Genetic Health, director of the division of reproductive genetics at Montefiore, and professor of clinical obstetrics and gynecology and women’s health at Einstein. The interview was conducted via email.
A breast cancer diagnosis, and its effect on a couple, are at the center of Samuel Simon’s ‘The Actual Dance.’
Special To The Jewish Week
Caring for a loved one who is terminally ill is one of the most agonizing things that a person can do. For Samuel Simon, a lawyer turned playwright who is now performing his one-man play, “The Actual Dance,” his wife’s breast cancer diagnosis launched both members of the couple on a harrowing journey into the workings of the human heart.